APA

Wong N. S., Buckman R. A., Clemons M., Verma S., Dent S., Trudeau M. E., Roche K., Ebos J., Kerbel R., Deboer G. E., Sutherland D. J. A., Emmenegger U., Slingerland J., Gardner S. & Pritchard K. I. (20100304). Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Wong Nan Soon, Buckman Robert A, Clemons Mark, Verma Shailendra, Dent Susan, Trudeau Maureen E, Roche Kathie, Ebos John, Kerbel Robert, Deboer Gerrit E, Sutherland Donald J A, Emmenegger Urban, Slingerland Joyce, Gardner Sandra and Pritchard Kathleen I. 20100304. Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Wong N. S., Buckman R. A., Clemons M., Verma S., Dent S., Trudeau M. E., Roche K., Ebos J., Kerbel R., Deboer G. E., Sutherland D. J. A., Emmenegger U., Slingerland J., Gardner S. and Pritchard K. I. (20100304). Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Wong Nan Soon, Buckman Robert A, Clemons Mark, Verma Shailendra, Dent Susan, Trudeau Maureen E, Roche Kathie, Ebos John, Kerbel Robert, Deboer Gerrit E, Sutherland Donald J A, Emmenegger Urban, Slingerland Joyce, Gardner Sandra and Pritchard Kathleen I. Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20100304.